These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38942475)

  • 1. Clarifications on the Intended Use of USP <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests.
    Tidswell EC; Tirumalai RS; Gross DD
    PDA J Pharm Sci Technol; 2024 Jun; 78(3):348-357. PubMed ID: 38942475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4A on Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15991-2. PubMed ID: 19507322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 5. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15992-3. PubMed ID: 19507323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 7. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 4B on Microbiological Examination of nonsterile products: Tests for Specified Microorganisms General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15989-90. PubMed ID: 19507320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Milliflex
    Gordon O; Goverde M; Staerk A; Roesti D
    PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological tests on oral pediatric medicines--requirements for an improved pharmacopoeia monograph.
    Long PF; Han J; Tuleu C; Wong IC
    Ann Pharmacother; 2006 Jan; 40(1):158-9. PubMed ID: 16368921
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality Control: microbial limit tests for nonsterile pharmaceuticals, part 2.
    Vu N; Lou JR; Kupiec TC
    Int J Pharm Compd; 2014; 18(4):305-10. PubMed ID: 25474859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP publishes enforceable chapter on sterile compounding.
    Thompson CA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigating Aberrant Results in Microbiological Examination of Nonsterile Product Assays.
    Booth C
    PDA J Pharm Sci Technol; 2020; 74(5):571-580. PubMed ID: 32467174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
    Shintani H
    Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological acceptance criteria, specifications of herbal drugs and herbal drug preparations in various pharmacopoeias: a global scenario.
    Munukuntla R; Tiwari A; Yadav RS; Jayanthy A; Verma SC; Singh RM
    Daru; 2024 Jun; 32(1):461-468. PubMed ID: 38613658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extemporaneously compounded sterile medications: relevance of new United States pharmacopeial standards to pain clinicians.
    Rusho WJ
    J Pain Palliat Care Pharmacother; 2004; 18(4):69-76. PubMed ID: 15760810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of the USP Analytical Microbiology Expert Committee during the 2000-2005 revision cycle.
    Sutton SV; Knapp JE; Porter D
    PDA J Pharm Sci Technol; 2005; 59(3):157-76. PubMed ID: 16048116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test.
    Clapp FL
    Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566
    [No Abstract]   [Full Text] [Related]  

  • 19. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An industry commentary on regulatory issues--microbiology.
    Moldenhauer JE
    PDA J Pharm Sci Technol; 2002; 56(2):60-4. PubMed ID: 11977405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.